Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | ACAA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ACAP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ACAT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ACER2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ACRV1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ACSL3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | ACVR1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |